These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7463499)

  • 21. Roles of electrophilic sulfuric acid ester metabolites in mutagenesis and carcinogenesis by some polynuclear aromatic hydrocarbons.
    Surh YJ; Miller JA
    Chem Biol Interact; 1994 Jun; 92(1-3):351-62. PubMed ID: 8033269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of mammary tumor susceptibility, mammary cell-mediated mutagenesis, and metabolism of polycyclic aromatic hydrocarbons in four types of rats.
    Moore CJ; Bachhuber AJ; Gould MN
    J Natl Cancer Inst; 1983 Apr; 70(4):777-84. PubMed ID: 6300505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural factors that enhance or attenuate the carcinogenicity of polycyclic aromatic hydrocarbons.
    Yang SK
    Prog Clin Biol Res; 1983; 132B():151-60. PubMed ID: 6634752
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons.
    Sayer JM; Whalen DL; Jerina DM
    Drug Metab Rev; 1989; 20(2-4):155-82. PubMed ID: 2680377
    [No Abstract]   [Full Text] [Related]  

  • 25. Tissue culture and experimental carcinogenesis.
    Mohr U; Emura M
    Exp Pathol; 1989; 36(4):221-31. PubMed ID: 2767212
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutagenic and carcinogenic properties of polycyclic aromatic hydrocarbons.
    Pashin YV; Bakhitova LM
    Environ Health Perspect; 1979 Jun; 30():185-9. PubMed ID: 446450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA?
    Geacintov NE
    Carcinogenesis; 1986 May; 7(5):759-66. PubMed ID: 3698204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycyclic aromatic hydrocarbon carcinogens.
    Dipple A; Cheng SC; Bigger CA
    Prog Clin Biol Res; 1990; 347():109-27. PubMed ID: 2217384
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemical carcinogenesis: a brief overview of the mechanism of action of polycyclic hydrocarbons, aromatic amines, nitrosamines, and aflatoxins.
    Selkirk JK
    Carcinog Compr Surv; 1980; 5():1-31. PubMed ID: 6992992
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism and activation of carcinogenic polycyclic hydrocarbons by human mammary cells.
    MacNicoll AD; Easty GC; Neville AM; Grover PL; Sims P
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1599-606. PubMed ID: 6774726
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitration of carcinogenic and non-carcinogenic polycyclic aromatic hydrocarbons results in products able to induce transformation of Syrian hamster cells.
    DiPaolo JA; DeMarinis AJ; Chow FL; Garner RC; Martin CN; Doniger J
    Carcinogenesis; 1983; 4(3):357-9. PubMed ID: 6831639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biotransformation enzymes : their role in carcinogenesis].
    Gielen J
    Actual Pharmacol (Paris); 1980; 32():57-76. PubMed ID: 6987832
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic activation pathways of cyclopenta-fused PAH and their relationship to genetic and carcinogenic activity.
    Nesnow S; Gold A; Mohapatra N; Sangaiah R; Bryant BJ; Rudo K; MacNair P; Ellis S
    Prog Clin Biol Res; 1986; 209A():515-22. PubMed ID: 3749064
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolism of aromatic amines.
    Gorrod JW; Manson D
    Xenobiotica; 1986; 16(10-11):933-55. PubMed ID: 3541401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian cell mutation and polycyclic hydrocarbon carcinogenesis.
    Brookes P; King HW; Osborne MR
    Carcinog Compr Surv; 1985; 10():433-47. PubMed ID: 3904995
    [No Abstract]   [Full Text] [Related]  

  • 36. Selection of carcinogens and related compounds tested for mutagenic activity.
    Poirier LA; Weisburger EK
    J Natl Cancer Inst; 1979 Apr; 62(4):833-40. PubMed ID: 372655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arene oxides: a new aspect of drug metabolism.
    Jerina DM; Daly JW
    Science; 1974 Aug; 185(4151):573-82. PubMed ID: 4841570
    [No Abstract]   [Full Text] [Related]  

  • 38. Mutagenesis and cell transformation of mammalian cells in culture by chemical carcinogens.
    Huberman E
    J Environ Pathol Toxicol; 1978; 2(1):29-42. PubMed ID: 722224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The participation of cytochrome P-450 in the formation of mutagenic and carcinogenic compounds and the use of this property in preventive medicine].
    Friedrich J; Pfeil D
    Pharmazie; 1985 Apr; 40(4):228-32. PubMed ID: 3892552
    [No Abstract]   [Full Text] [Related]  

  • 40. Biologically-active and chemically-reactive polycyclic hydrocarbon metabolites.
    Phillips DH; Grover PL
    IARC Sci Publ; 1984; (59):47-61. PubMed ID: 6545297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.